Phase II study of neoadjuvant treatment with doxorubicin,docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Phase II study of neoadjuvant treatment with doxorubicin,docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

Authors:	Gumersindo Pérez Manga Parham Khosravi Shahi Miguel Méndez Ureña Rosa Quiben Pereira María Isabel Palomero Plaza Yann Izarzugaza Peron Ricardo González Del Val Joaquín Belón Carrión Esperanza Pérez Cañón Pilar García Alfonso

Affiliation:	1.Servicio de Oncología Médica,Hospital General Universitario “Gregorio Mara?ón”,Madrid,Spain;2.Servicio de Oncología Médica,Hospital de Mostoles,Madrid,Spain;3.Servicio de Oncología Médica,Hospital Virgen de las Nieves,Granada,Spain

Abstract:	Background Pathologic complete response (pCR) after preoperative systemic chemotherapy (PSCh) is associated with better outcome in locally advanced breast cancer (LABC).

Keywords:
本文献已被 SpringerLink 等数据库收录！